Research

Developing splice-switching oligonucleotides as therapeutics for CEP290-related retinal dystrophy in retinal organoid models

Triplet repeat expansion-associated inherited corneal disease: from genetic mechanism to clinical consequences

Microglia circadian disruption in progression of diabetic retinopathy

miRNA-mediated therapy for the treatment of glaucoma

Investigating the role of micro RNA - thought to be an integral part of the disease mechanism in glaucoma - and explore its therapeutic potential for the condition through pre-clinical testing.

Generating improved cells for the treatment of limbal stem cell deficiency

Researchers want to create a bank of “off the shelf” limbal stem cells that could be transplanted into any individual.

Identifying novel therapies for inherited eye disease

Investigating photoreceptor death which will act as a basis to identify novel therapies for inherited eye disease.

Oxford Cognitive Screen - visual impairment adaptation

Co-funded with the British and Irish Orthoptic Society (BIOS), this research aims to adapt the Oxford Cognitive Screen to accommodate for those with visual impairment.

Identifying measurements to predict childhood secondary glaucoma risk

ARGO-1: Study of Anterior segment imaging based Risk stratification of childhood secondary Glaucoma.

Investigation of genetic susceptibility to retinal toxicity in patients taking hydroxychloroquine